Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Extemporaneous Preparation of Sertraline Cream for Transdermal Administration

Author(s):  Wynn Tom, Goetsch Daniel

Issue:  May/Jun 2011 - Volume 15, Number 3
View All Articles in Issue

Page(s):  200-203

Extemporaneous Preparation of Sertraline Cream for Transdermal Administration Page 1
Extemporaneous Preparation of Sertraline Cream for Transdermal Administration Page 2
Extemporaneous Preparation of Sertraline Cream for Transdermal Administration Page 3
Extemporaneous Preparation of Sertraline Cream for Transdermal Administration Page 4

Download in electronic PDF format for $65

Abstract:  The antidepressant effects of selective serotonin reuptake inhibitors are currently attributed to responses exhibited after periods of prolonged administration. Postulations have been formed accrediting the successful treatment of anxiety-related disorders with selective serotonin reuptake inhibitors to a similar mechanism of action as displayed in the treatment of depression. One of the drugs in this class is sertraline. This article provides a case report of a pediatric patient diagnosed with an anxiety disorder who was treated with transdermal sertraline. The compounding of dosage forms tailored to meet patient-specific needs may be an integral part in the successful delivery of selective serotonin reuptake inhibitor therapy.

Related Keywords: Tom Wynn, RPh, Daniel Goetsch, transdermal administration, sertraline, anxiety disorders, children, case report, formulation, selective serotonin reuptake inhibitor, SSRI

Related Categories: FORMULATIONS, MENTAL HEALTH, PEDIATRICS, CASE REPORTS, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Veterinary Transdermal Medications: A to Z
Davidson Gigi S
Mar/Apr 2003
Pg. 106-113

Extemporaneous Preparation of Sertraline Cream for Transdermal Administration
Wynn Tom
, Goetsch Daniel
May/Jun 2011
Pg. 200-203

Case Report: Transdermal Fluoxetine as Therapy for Feline Anxiety
Fields Shannon W
Nov/Dec 2006
Pg. 418

Absorption of Transdermal Fluoxetine Compounded in a Lipoderm Base Compared to Oral Fluoxetine in Client-owned Cats
Eichstadt Lauren R
, Corriveau Lorraine A, Moore George E, Knipp Gregory T, Cooper Bruce R, Gwin Wilson E
May/Jun 2017
Pg. 242-246

Sertraline Hydrochloride 10-mg/mL Oral Suspension
Allen Loyd V Jr
Jul/Aug 2017
Pg. 318

Unlicensed Transdermal Medications in Feline Patients: Three Case Reports
Urwin Craig
, Jean Linda, Carvalho Maria, Robson-Laws Michael
Nov/Dec 2022
Pg. 468-472

Compounding for Pediatric Patients: Case Reports and Formulations
Mixon William
, Angelle Patricea, Yoch Douglas
Jan/Feb 2009
Pg. 6-12

Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Williams LaVonn A
, Fokken Dawn
Sep/Oct 2009
Pg. 386-389

Compounding Naltrexone for the Treatment of Autism
Wynn Tom
, Brunetti Sarah
Jul/Aug 2009
Pg. 296-299

Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases
Mixon William
, Helms Scott R
Sep/Oct 2008
Pg. 392-397

Particle Measuring Systems - USP <797> Environmental Monitoring Solutions